An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews
Livia Theodor, Eitan Friedman(University of Pennsylvania), Revital Bruchim Bar-Sade(Sheba Medical Center), Gilad Ben‐Baruch(Sheba Medical Center), Anna Kruglikova(Sheba Medical Center), Gideon Rechavi(Tel Aviv University), Baruch Modan(Tel Aviv University), Ronit Shiri‐Sverdlov(Maastricht University), S Risel(Sheba Medical Center), Galit Hirsh Yechezkel(Sheba Medical Center), MZ Papa(Sheba Medical Center)
Cited by 9
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control Studies
|JNCI Journal of the National Cancer Institute|1990|756
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538